Wealthy gain as world demands fair access
May 05, 2021 | 08:00
While some of the world’s largest vaccine makers have committed to increase COVID-19 vaccine access to middle and low-income countries, there remains uncertainty over patent waivers.
Pharmaceutical giants shell out billions to shareholders amid vaccine apartheid
April 26, 2021 | 15:10
Pfizer, Johnson & Johnson, and AstraZeneca have paid enough in dividends and stock buybacks to shareholders to inoculate the population of Africa.
EU to get 50 million Pfizer doses early as US prolongs J&J pause
April 15, 2021 | 09:58
The European Union said Wednesday that it is expecting 50 million Pfizer coronavirus vaccine doses earlier than expected, as the United States said it would continue a pause in vaccinations using the Johnson & Johnson shot for at least another week so regulators can assess possible blood clot links.
Johnson & Johnson to delay European Covid-19 vaccine rollout
April 14, 2021 | 11:32
Johnson & Johnson said Tuesday it will delay rollout of its Covid-19 vaccine in Europe after US authorities moved to suspend use of the shot due to health concerns.
AstraZeneca, Johnson & Johnson COVID-19 vaccine trials back on track in US
October 24, 2020 | 20:48
WASHINGTON: Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States on Friday (Oct 23), providing a glimmer of hope as the number of cases skyrockets across the country.
Johnson & Johnson moves to buoy investors over paused Covid vaccine trial
October 14, 2020 | 11:06
US pharmaceutical giant Johnson & Johnson sought Tuesday to reassure investors after its stock slumped on an announcement that it was pausing a Covid-19 vaccine trial over a sick participant.
J&J implored to verify powder safety
September 02, 2020 | 15:00
International healthcare supplier Johnson & Johnson, despite facing thousands of lawsuits in the United States and Canada as its talcum powder has been allegedly harming women for years, has continued to sell the signature product in other countries across the globe, including Vietnam.
Brazil approves final tests of J&J virus vaccine
August 19, 2020 | 10:48
Brazilian health regulators said Tuesday they had approved Johnson & Johnson's experimental vaccine against the new coronavirus for the final stage of clinical trials, the fourth vaccine to receive widespread testing in the hard-hit country.
US signs $1 billion vaccine deal with Johnson & Johnson
August 06, 2020 | 14:23
The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.
Pharma groups to profit from virus?
May 19, 2020 | 10:10
The top 10 global pharmaceutical companies are being scrutinised and advised not to prevent or delay a vaccine for COVID-19 from reaching vulnerable people to gain profits, triggering global concerns over their social responsibility.
Johnson & Johnson ordered to pay US$344 million over pelvic mesh claims
January 31, 2020 | 10:22
A US judge on Thursday (Jan 30) ordered Johnson & Johnson to pay US$344 million for false and deceptive marketing of pelvic mesh products used by tens of thousands of women in California.
Improving the quality of medical examination and hospital treatment
June 29, 2019 | 19:29
The MoH and the Centre of Developing Medical Management Capacity organised a training course for 60 hospital quality assessment auditors in southern Vietnam.
J&J ordered to pay US$4.7 billion in Missouri asbestos cancer case
July 13, 2018 | 10:34
A Missouri jury on Thursday ordered Johnson & Johnson to pay a record US$4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.
Missouri appeals court tosses US$55 million J&J talc-powder verdict
July 03, 2018 | 13:17
A Missouri appeals court on Friday threw out a US$55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using its talc-based products, including J&J's Baby Powder, for feminine hygiene.
J&J baby powder litigation takes new focus with asbestos claims
April 16, 2018 | 15:10
A US$117 million verdict against Johnson & Johnson and a supplier could open a new front for thousands of cases claiming the widely-used product caused cancer, legal experts and plaintiffs lawyers said on Monday (Apr 16).
1 2
Mobile Version